CAS RN: 144985-19-3
4-Methoxyphenyl 3-O-Allyl-β-D-galactopyranoside
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 144985-19-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
≥95%
0
Out of Stock
Shanghai
Inquiry
144985-19-3 / (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-methoxyphenoxy)-4-prop-2-enoxyoxane-3,5-diol
Standard CAS: 144985-19-3
Multi CAS: No
Basic Information
copy
CAS
144985-19-3 copy
Multi CAS
No copy
Molecular Formula
C16H22O7 copy
Molecular Weight
326.340000 copy
Exact Mass
326.136553 copy
SMILES
COC1=CC=C(C=C1)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)OCC=C)O copy
InChI
InChI=1S/C16H22O7/c1-3-8-21-15-13(18)12(9-17)23-16(14(15)19)22-11-6-4-10(20-2)5-7-11/h3-7,12-19H,1,8-9H2,2H3/t12-,13+,14-,15+,16-/m1/s1 copy
InChIKey
DXDVGRALJDFCOJ-DGADGQDISA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
23 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.5 copy
Rotatable bonds
7 copy
H-bond acceptors
7 copy
H-bond donors
3 copy
Molar refractivity
81.32 copy
TPSA
97.61 copy
LogP / Solubility
WLOGP
0.08 copy
MLOGP
0.09 copy
XLogP3
0.5 copy
Consensus LogP
0.22 copy
Log S (ESOL)
-1.65 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-2.3 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.69 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-4.65 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
Yes copy
Synthetic Accessibility
5 copy